Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenax Therapeutics (TENX) Payables (2016 - 2017)

Historic Payables for Tenax Therapeutics (TENX) over the last 6 years, with Q3 2017 value amounting to $579386.0.

  • Tenax Therapeutics' Payables fell 5839.46% to $579386.0 in Q3 2017 from the same period last year, while for Sep 2017 it was $579386.0, marking a year-over-year decrease of 5839.46%. This contributed to the annual value of $727599.0 for FY2016, which is N/A changed from last year.
  • As of Q3 2017, Tenax Therapeutics' Payables stood at $579386.0, which was down 5839.46% from $434195.0 recorded in Q2 2017.
  • In the past 5 years, Tenax Therapeutics' Payables registered a high of $1.5 million during Q2 2016, and its lowest value of $434195.0 during Q2 2017.
  • Its 4-year average for Payables is $997078.1, with a median of $972483.0 in 2015.
  • Its Payables has fluctuated over the past 5 years, first skyrocketed by 7080.84% in 2013, then tumbled by 7146.22% in 2017.
  • Tenax Therapeutics' Payables (Quarter) stood at $1.0 million in 2013, then decreased by 6.01% to $972483.0 in 2015, then dropped by 25.18% to $727599.0 in 2016, then fell by 20.37% to $579386.0 in 2017.
  • Its Payables stands at $579386.0 for Q3 2017, versus $434195.0 for Q2 2017 and $1.4 million for Q1 2017.